Physician profile
Fiona I Masters
NPI 1194885681
$6,072.06
in general payments reported to CMS, 2019-2025
38 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Adolescent Medicine (Internal Medicine) provider received nationally (typical 2025 total: $165).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $937 · 2020: $930 · 2021: $1,312 · 2022: $659 · 2023: $1,285 · 2024: $709 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,233.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $777.55 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $738.39 | 2019-2025 | Spravato |
| Lilly USA, LLC | $497.48 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $470.78 | 2021-2024 | |
| Amgen INC. | $426.25 | 2019-2023 | Prolia, Evenity, Repatha |
| Novo Nordisk INC | $368.02 | 2019-2024 | Ozempic, Rybelsus |
| Amarin Pharma, INC. | $340.19 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $327.59 | 2019-2024 | Airsupra, Farxiga, Breztri |
| Novartis Pharmaceuticals Corporation | $296.25 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $218.85 | 2022-2024 | |
| Pfizer INC. | $200.36 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $197.78 | 2019-2023 | Tradjenta |
| Merck Sharp & Dohme LLC | $190.92 | 2019-2023 | Verquvo, Dificid, Belsomra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.16 | 2022-2024 | Xifaxan, Trulance |
| E.R. Squibb & Sons, L.L.C. | $122.13 | 2019-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fiona Masters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.